Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26 |...

Pharma sector: Firms to clock 11% sales, EBITDA growth in Q1FY26

Сообщение

India's pharmaceutical sector is projected to experience an 11% year-on-year growth in sales and EBITDA for Q1 FY26, driven by strong market performance across various regions. The hospital segment is expected to lead with a 17% growth, while diagnostics firms anticipate a 14% sales increase. Government initiatives and investments in R&D further support the industry's optimistic outlook.

Read Full Article

Войдите, чтобы отмечать, делиться и комментировать!

National

National Youth Festival to be held on July 12

KATHMANDU: The National Youth Festival is set to take place on July 12 with the objective of...

От 0 5

Sports

IND vs ENG: Mohammed Siraj's reply to Virat Kohli will melt your heart

Virat Kohli led the chorus of praise for Shubman Gill and Team India after their dominant victory...

От 0 8

Sports

'Not many better feelings in cricket': Ex-cricketers laud India after Edgbaston triumph

India's resounding 336-run victory over England at Edgbaston, leveling the series 1-1, drew...

От 0 8

Business

Top stocks to buy: Stock recommendations for the week starting July 7, 2025 - check list

Stock market recommendations: Motilal Oswal Financial Services recommends INOX Wind, poised to...

От 0 12

Business

‘In its conclusion phase…’: India-US mini trade deal coming soon? These sectors may be excluded as Donald Trump’s tariff deadline nears

India and the United States are nearing a mini trade deal, excluding sensitive sectors like dairy...

От 0 10